Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | AMGN | VRTX | REGN | BMY |
| Company | Protagonist Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 25.25 | 276.11 | 396.20 | 892.11 | 44.40 |
| High | 25.44 | 276.12 | 396.69 | 896.48 | 44.50 |
| Low | 24.91 | 272.35 | 392.50 | 885.01 | 43.97 |
| Last | 25.14 | 274.63 | 394.51 | 894.07 | 44.58 |
| Change | -0.42 | -1.75 | -1.69 | +1.59 | -0.06 |
| % Change | -1.64% | -0.63% | -0.43% | +0.18% | -0.13% |
| Volume | 51,667 | 304,405 | 124,347 | 87,943 | 3,272,011 |
| 20-Day Average Volume | 493,214 | 2,099,833 | 891,714 | 439,423 | 13,171,282 |
| Previous Close | 25.56 | 276.38 | 396.20 | 892.48 | 44.64 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.62 | 269.56 | 399.40 | 911.69 | 48.63 |
| 20-Day Raw Stochastic | 19.24% | 83.99% | 21.24% | 22.05% | 2.65% |
| 20-Day Relative Strength | 41.67% | 49.91% | 41.54% | 38.34% | 27.70% |
| Weighted Alpha | +8.85 | +12.80 | +12.40 | +15.54 | -36.18 |
| Today's Opinion | 24% Buy | 40% Sell | 8% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 24% Buy | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 80% Buy | 24% Buy | 56% Buy | 96% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.22% since 04/23/24 | +0.27% since 04/23/24 | -2.18% since 04/23/24 | -1.42% since 04/23/24 | -9.71% since 04/23/24 |
| Low | 24.22 on 04/26/24 | 265.72 on 04/26/24 | 392.50 on 04/30/24 | 875.22 on 04/26/24 | 44.00 on 04/30/24 |
| High | 27.61 on 04/24/24 | 276.86 on 04/29/24 | 406.83 on 04/24/24 | 915.70 on 04/24/24 | 49.04 on 04/24/24 |
| 1-Month | |||||
| %Chg | -12.96% since 03/28/24 | -3.53% since 03/28/24 | -5.24% since 03/28/24 | -7.07% since 03/28/24 | -18.43% since 03/28/24 |
| Low | 24.22 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.00 on 04/30/24 |
| High | 29.21 on 04/09/24 | 283.91 on 04/02/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 | 54.23 on 04/01/24 |
| 3-Month | |||||
| %Chg | -1.72% since 01/30/24 | -12.82% since 01/30/24 | -11.21% since 01/30/24 | -6.81% since 01/30/24 | -10.44% since 01/30/24 |
| Low | 24.22 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.00 on 04/30/24 |
| High | 33.34 on 03/01/24 | 329.72 on 02/05/24 | 444.07 on 01/31/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +76.33% since 10/30/23 | +4.21% since 10/30/23 | +10.81% since 10/30/23 | +15.01% since 10/30/23 | -13.69% since 10/30/23 |
| Low | 13.76 on 10/31/23 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 772.84 on 10/31/23 | 44.00 on 04/30/24 |
| High | 33.34 on 03/01/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,489,509 | 148,243,600 | 102,401,456 | 97,960,392 | 90,489,744 |
| Shares Outstanding, K | 58,275 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 60,000,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -78,960,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 60,000,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | 27,340,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 2.02 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.44 on 02/27/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.48 | 29.57 | 23.50 | 42.71 |